Vivpro
Vivpro Corp is a US-based biointelligence software company that provides GenAI-powered regulatory intelligence (RIA) and automated regulatory document authoring (REGAIN), plus strategic consulting, to pharmaceutical, biotech, medical device, CRO, and life-sciences investor clients.
- Company typePrivate
- Founded2020
- HeadquartersLansdale, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Vivpro does
Vivpro Corp is a US-based biointelligence software company founded in 2020 that builds GenAI-powered platforms for pharmaceutical, biotechnology, medical device, CRO, and life-sciences investor clients. The company operates two core products: RIA (R&D Intelligence Assistant), an AI-powered regulatory intelligence platform aggregating data from 9 agencies and 150+ sources across 300K+ drugs/biologics/devices, 600K+ clinical trials, and 50MM+ R&D pages, and REGAIN (Regulatory Submissions Excellence using Generative AI Navigator), a document-agnostic GenAI platform that transforms source data into submission-ready regulatory documents such as CSRs, protocols, SAPs, and eCTD modules. Both products rely on natural language processing, generative AI, and knowledge retrieval to support regulatory precedence analysis, labeling comparisons, real-time guidance tracking, and automated authoring with collaboration and version control features, backed by SOC2 Type II and ISO 27001 security certifications.
The company monetizes through annual enterprise SaaS subscriptions sold via a sales-led motion with quote-based pricing, supplemented by Strategic Consulting services delivered by former FDA officials and pharmaceutical executives. Customer acquisition leverages webinars, industry conferences (RAPS Convergence, DIA, Bio-IT World), thought-leadership content, and a 'Request Demo' conversion funnel, with named enterprise testimonials from global pharmaceutical regulatory and clinical pharmacology leaders. Vivpro is founder-owned and operated, with no disclosed external funding rounds, and runs a multi-region footprint spanning Lansdale, PA (headquarters), Jersey City, NJ, Herndon, VA, and an engineering/R&D office in Pune, India, with leadership drawn from FDA, Merck, Otsuka, Pfizer, and Wyeth.
Vivpro firmographics
Firmographics- Name
- Vivpro
- Legal name
- Vivpro Corp
- Website
- https://vivpro.ai
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vivpro Corp is a US-based biointelligence software company that provides GenAI-powered regulatory intelligence (RIA) and automated regulatory document authoring (REGAIN), plus strategic consulting, to pharmaceutical, biotech, medical device, CRO, and life-sciences investor clients.
- Ownership category
- akta.pro rank
Vivpro industry classification
Industry- Product category
- Regulatory Intelligence Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001) (HDAAAMAE)
- akta.pro secondary industries
- AI Governance, Risk & Compliance (GRC) Platforms (HDAAAMAA), Model Transparency, Explainability & Interpretability (XAI) (HDAAAMAB)
Keywords
Where Vivpro is headquartered
LocationHeadquarters
- HQ city
- Lansdale
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Vivpro business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS Platform Subscriptions: Annual and multi-year subscription access to RIA and REGAIN platforms, with tiered pricing based on usage and features. Enterprise clients include Top 20 Pharma companies.
- Strategic Consulting Services: Expert consulting engagements for regulatory strategy, clinical development planning, and drug development optimization. Services include regulatory submissions (Pre-IND, IND, EOP2, NDA, BLA), pediatric plans, MIDD strategy, and IB review.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription for pharmaceutical companies |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Vivpro product offering
Product offeringCore offering
Vivpro (VivproAI) is a bio intelligence software platform that provides AI-powered regulatory intelligence and document automation for pharmaceutical, biotech, medical device developers, CROs, and life sciences investors. The company offers two integrated GenAI products—RIA (R&D Intelligence Assistant) for global regulatory intelligence and landscape analysis, and REGAIN (Regulatory Submissions Excellence using Generative AI Navigator) for automated generation of regulatory submission documents—complemented by expert strategic consulting services delivered by former FDA officials.
Product overview
Vivpro offers a unified biointelligence platform comprising two integrated GenAI-powered products—RIA (R&D Intelligence Assistant) for regulatory intelligence and clinical decision support, and REGAIN for automated regulatory document generation—complemented by expert Strategic Consulting services. The platform leverages AI to help pharmaceutical and biotech companies accelerate drug development by providing real-time regulatory intelligence, automated document creation, and expert strategic guidance.
Differentiator
Problem solved
Functional benefit
Brands
- RIA: R&D Intelligence Assistant - AI-powered regulatory intelligence platform providing access to global approval landscapes, submission requirements, labeling insights, and application transitions
- REGAIN
- VivproAI
Products and services
- RIA (R&D Intelligence Assistant) AI-powered bio-intelligence platform providing automated clinical and regulatory intelligence for pharmaceutical, biotech, device developers, CROs, and investors. Offers natural language search, regulatory precedent analysis, landscape and feasibility analysis, AI-powered labeling comparisons, ChatRIA conversational interface, and real-time guidance tracking across global regulatory agencies. Covers 9 agencies, 150+ data sources, 300K+ drugs/biologics/devices, 600K+ clinical trials, and 50MM+ R&D pages.
- REGAIN (Regulatory Submissions Excellence using Generative AI Navigator) GenAI-powered, document-agnostic platform that automates creation of regulatory and scientific documents across the product lifecycle. Transforms tables, TLFs, and other data into submission-ready reports including CSRs, protocols, statistical analysis plans (SAPs), and eCTD modules. Features real-time collaboration with role-based permissions, commenting, and version control. Generates first drafts in less than 1 day.
- Strategic Consulting Expert consulting services for lean drug development strategy, clinical development planning, regulatory strategy, and submission support. Services include regulatory submissions assistance (Pre-IND, IND, EOP2, NDA, BLA), pediatric plans, MIDD strategy, IB review, and Project Optimus support. Delivered directly by Vivpro's team of former FDA officials and industry experts.
Quantifiable outcome
- 10x more think time for strategic decisions
- +3 more outcomes
Companies that use Vivpro
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles5 records
Vivpro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Vivpro partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Critical Path Institute (C-Path)coreFormalized Memorandum of Understanding (MOU) to enhance C-Path's drug development acceleration capabilities through Vivpro's AI-driven regulatory strategy and intelligence platform. The partnership will deploy VivproAI to continuously monitor and quantify C-Path's impact on accelerating drug development, and inform regulatory strategies of public-private partnerships coordinated by C-Path. Both parties pledged to co-sponsor workshops and training for scientists in drug development and regulatory science.
- Joan Korth-Bradley (Individual Expert)coreJoan Korth-Bradley, PharmD, PhD, FCP, FAAPS joined Vivpro AI as Distinguished Scientist. She brings over 30 years of experience in drug development at Pfizer and Wyeth, focusing on clinical pharmacology across oncology, cardiology, anti-infectives, rheumatology, and rare diseases. She contributes to Vivpro's consultancy services and webinar series.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Vivpro competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Dominant cloud SaaS provider for life sciences with Veeva Vault RIM, Vault Quality, and Vault Clinical — directly overlapping with Vivpro's regulatory intelligence and document automation value proposition across large pharma customers.
- IQVIA: Global life sciences data, analytics, and technology company; competes through its RIM, regulatory intelligence, and AI/data offerings, and via its Linguamatics NLP platform for biomedical text mining.
- Parexel: Large CRO with regulatory strategy and submission consulting practices; overlaps with Vivpro's Strategic Consulting services and increasingly uses AI tools for regulatory document generation.
Direct peers
- Certara: Publicly traded biosimulation and regulatory science technology company serving pharma and biotech, with software and services spanning regulatory submissions, drug development, and pharmacometrics — directly comparable to Vivpro's regulatory intelligence and consulting offerings.
- ArisGlobal: Life sciences technology vendor providing regulatory information management, safety, and pharmacovigilance platforms; directly competes with Vivpro's RIA in regulatory intelligence and increasingly in GenAI-driven submission automation.
- Pharma Intelligence (Informa): Provides regulatory intelligence, clinical trial data, and drug development analytics (e.g., Citeline, Pink Sheet) — directly competing with Vivpro's RIA on regulatory landscapes, precedent analysis, and pharma intelligence subscriptions.
Emerging players
- Saama Technologies: AI-focused life sciences technology company with clinical data, regulatory, and commercial analytics offerings; comparable as an AI-native peer pursuing pharma regulatory and submission automation.
- Tempus AI: AI-driven precision medicine and life sciences data platform; adjacent comparability through AI-for-pharma data assets and enterprise pharma commercialization, with growing regulatory and clinical intelligence capabilities.
- Trial Library: AI-driven clinical trial feasibility and sponsor-CRO matching platform; comparable as a smaller AI-native vendor applying data and ML to pharmaceutical R&D decision-making.
- Regard: AI clinical decision support company for hospitals; less directly overlapping, but comparable as an AI-native healthtech vendor pursuing enterprise healthcare buyers with regulated data and compliance requirements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Vivpro social profiles
Digital presenceVivpro compliance and trust
Trust signalCompliance2 records
Vivpro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivpro leadership team
Management profileNumber of profiles
Profiles4 records
Vivpro funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivpro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivpro
What does Vivpro do?
Vivpro (VivproAI) is a bio intelligence software platform that provides AI-powered regulatory intelligence and document automation for pharmaceutical, biotech, medical device developers, CROs, and life sciences investors. The company offers two integrated GenAI products—RIA (R&D Intelligence Assistant) for global regulatory intelligence and landscape analysis, and REGAIN (Regulatory Submissions Excellence using Generative AI Navigator) for automated generation of regulatory submission documents—complemented by expert strategic consulting services delivered by former FDA officials.
Is Vivpro a public or private company?
Vivpro is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vivpro founded?
Vivpro was founded in 2020. It employs 11 to 50 people.
Where is Vivpro based?
Vivpro is headquartered in Lansdale, United States, in the North America region.
How does Vivpro make money?
Two revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are strategic Consulting Services.
Who are Vivpro's main competitors?
Broad incumbents on record are Veeva Systems, IQVIA and Parexel. Direct peers are Certara, ArisGlobal and Pharma Intelligence (Informa). Emerging players are Saama Technologies, Tempus AI, Trial Library and Regard.
Does Vivpro have an API?
No public API is recorded for Vivpro.
What industry is Vivpro in?
Vivpro's product category is Regulatory Intelligence Software. Its primary akta.pro industry code is HDAAAMAE, Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001), with a secondary code of HDAAAMAA, AI Governance, Risk & Compliance (GRC) Platforms. Its NAICS code is 513210 and its SIC code is 7372.